Krsnaa Diagnostics Limited (NSE:KRSNAA)
560.90
-1.00 (-0.18%)
May 22, 2026, 3:29 PM IST
Krsnaa Diagnostics Revenue
Krsnaa Diagnostics had revenue of 1.81B INR in the quarter ending December 31, 2025, with 3.83% growth. This brings the company's revenue in the last twelve months to 7.66B, up 9.88% year-over-year. In the fiscal year ending March 31, 2025, Krsnaa Diagnostics had annual revenue of 7.17B with 15.74% growth.
Revenue (ttm)
7.66B
Revenue Growth
+9.88%
P/S Ratio
2.38
Revenue / Employee
2.21M
Employees
3,471
Market Cap
18.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 7.17B | 975.27M | 15.74% |
| Mar 31, 2024 | 6.20B | 1.33B | 27.20% |
| Mar 31, 2023 | 4.87B | 316.73M | 6.95% |
| Mar 31, 2022 | 4.55B | 589.94M | 14.88% |
| Mar 31, 2021 | 3.96B | 1.38B | 53.41% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 584.62B |
| Cipla | 277.12B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 110.67B |
| Indoco Remedies | 18.45B |
| Shalby | 11.19B |
| Windlas Biotech | 9.22B |
| Beta Drugs | 3.96B |
Krsnaa Diagnostics News
- 3 months ago - Krsnaa Diagnostics Transcript: Q3 25/26 - Transcripts
- 3 months ago - Krsnaa Diagnostics Quarterly report: Q3 2026 - Filings
- 3 months ago - Krsnaa Diagnostics Slides: Q3 2026 - Filings
- 3 months ago - Krsnaa Diagnostics Transcript: Q3 25/26 - Transcripts
- 3 months ago - Krsnaa Diagnostics Quarterly report: Q3 2026 - Filings
- 3 months ago - Krsnaa Diagnostics Slides: Q3 2026 - Filings
- 3 months ago - Why are Krsnaa Diagnostics shares down 3% today? Explained - Business Upturn
- 5 months ago - Krsnaa Diagnostics approves Rs 430 crore fundraise via NCDs - Business Upturn